Open Nav

Thorsten Melcher

Chief Business Officer

Xyphos Biosciences, Inc.

Dr. Melcher joined Xyphos in April 2018 to lead the business and corporate development activities. Previously he served in business development roles at Calico, Johnson & Johnson Innovation, Varian Medical Systems, and Saegis Pharmaceuticals. Earlier in his career, he led scientific teams and was co-founder of AGY Therapeutics and EnVivo Pharmaceuticals. He earned his MSc equivalent degree from the University of Hannover, and a PhD equivalent degree from the Center for Molecular Biology (ZMBH) in Heidelberg. Subsequently, he conducted postdoctoral research at ZMBH and the University of California, San Francisco

This speaker's sessions: